Must Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,198
Closed -$215K 27
2023
Q2
$215K Sell
6,198
-5,596
-47% -$191K 0.59% 21
2023
Q1
$440K Buy
+11,794
New +$553K 1.09% 13
2021
Q4
Sell
-6,388
Closed -$253K 50
2021
Q3
$253K Hold
6,388
0.16% 35
2021
Q2
$292K Sell
6,388
-33,968
-84% -$1.5M 0.21% 26
2021
Q1
$1.66M Buy
40,356
+6,106
+18% +$279K 1.3% 14
2020
Q4
$1.46M Buy
+34,250
New +$1.23M 1.04% 17

Other funds holding HALO

Must Asset Management's HALO Position: Q3 2023 in Review

Must Asset Management sold out of Halozyme (HALO) in Q3 2023, closing a stake of 6,198 shares — an estimated $215K sold.

Must Asset Management first reported a position in HALO in Q4 2020 and held it in 6 quarters. The position peaked at $1.66M in Q1 2021. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • Must Asset Management reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
  • Must Asset Management sold 6,198 Halozyme shares in Q3 2023, an estimated $215K.
  • Must Asset Management first reported a position in Halozyme in Q4 2020 and held it in 6 quarters.
  • Must Asset Management's Halozyme position peaked at $1.66M in Q1 2021.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on Must Asset Management's 13F filing for Q3 2023, filed 7 Nov 2023.